Position in HLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$189,678
New position
Shares Held
20,330
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#294
of 639 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 94%
Shared 0%
None 6%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $2,444,509 across 5 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (7.8% of the industry book) .
All Filings in HLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $189,678 | 20,330 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||